Breast Clinical Trial
Official title:
A Prospective Multi-center Case Collection Study of Breast Imaging Examinations From Women to Evaluate the Non-inferiority of QT Ultrasound Compared to Digital Mammography-Digital Breast Tomography (DM-DBT)
Brief Summary: The QT Ultrasound system is an automated scanner which transmits pulsed ultrasound plane waves through the breast, as well as collects reflected ultrasound output. As the patient lays prone on a table, the breast is submerged in a warm water bath. The transmitter and receiver assembly moves around the suspended breast to record data for successive sub-volumes of targeted tissue. More than 2000 elements in the curvilinear transducer's array encircle the breast to gather data from the tissue structures of the breast, from nipple to chest wall. Information gathered from this automated QT scan encompasses the entire breast which is currently not commercially available using any other ultrasound technology.
This is a prospective, multicenter, multi-arm case collection study, with IRB approval. The study will follow an adaptive design with an initially planned total enrollment of approximately 600 cases to include both benign and malignant cases, representative of all tissue densities. The images and clinical data accrued in this prospective case collection will be used for creation of a database to facilitate future reader's studies, publications, building teaching files, and future marketing for QT Ultrasound. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04333706 -
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT05016310 -
A Study of High-Dose Vit D Versus Standard of Care Vit D Supplementation
|
N/A | |
Completed |
NCT00026689 -
Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols
|
||
Active, not recruiting |
NCT04715802 -
Options on the Breast Reconstruction Timing and Method After Removal of Polyacrylamide Hydrogel
|
||
Recruiting |
NCT05720039 -
Robotic vs. Open NSM for Early Stage Breast Cancer
|
N/A | |
Recruiting |
NCT06157879 -
Measuring Electrical Properties of Breast Tissues
|
N/A | |
Completed |
NCT00277069 -
Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer
|
Phase 1/Phase 2 | |
Recruiting |
NCT06083415 -
Early Breast Growth in Girls Aged 6 to 8 Years in the Current Environmental Context
|
N/A | |
Active, not recruiting |
NCT02734004 -
A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.
|
Phase 1/Phase 2 | |
Recruiting |
NCT03047122 -
Detection of Breast Lesions by Automatic Breast US
|
N/A | |
Withdrawn |
NCT01114984 -
Post-Breast Procedure Pain Syndrome Study
|
N/A | |
Recruiting |
NCT05290402 -
Development of an Application-Based Digital Navigator for Perioperative Breast Surgery Patients
|
||
Active, not recruiting |
NCT01078662 -
Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats
|
Phase 2 | |
Not yet recruiting |
NCT05663801 -
Magnesium Sulphate Versus Ketamine as an Adjuvant to Bupivacaine in Pectoral Nerve Block During Mastectomy
|
Phase 2 | |
Terminated |
NCT00277004 -
Physiological Biomarkers of Cancer Treatment Related Fatigue in Women With Breast Cancer.
|
||
Completed |
NCT04524728 -
Patterns of Treatment and Outcome of Palbociclib Plus Endocrine Therapy
|
||
Withdrawn |
NCT00845078 -
Prospective Outcomes After Reconstruction and Radiotherapy for Breast Cancer
|
N/A | |
Completed |
NCT00972205 -
Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors
|
N/A | |
Recruiting |
NCT04174742 -
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
|
||
Completed |
NCT00064857 -
Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors
|
Phase 2 |